搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
6 小时
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adultsCosibelimab PDUFA goal date of December 28 for ...
1 天
Telangana DCA raids uncover illegal clinic and drug sales
Telangana DCA raids unauthorised medical practitioner, uncovers illegal drug sales, seizes medicines worth thousands in two districts.
Richmond
2 天
The People's Pharmacy: Take a gun to a knife fight with cold sores
The generic oral medication is reasonably affordable even without insurance. The People's Pharmacy: Don't blow your stomach ...
2 天
Sudden syphilis retreat in gay men is most likely tied to preventive antibiotic use
A new proven protocol in which doxycycline is used to prevent sexually transmitted infections, called doxyPEP, has been an ...
4 天
People’s Pharmacy: Ask dermatologist about better remedy for cold sores
A 5-gram tube of Zovirax cream runs more than $200. A month’s supply of valacyclovir (500 milligrams) tablets costs between ...
9 天
Fortress Biotech’s Majority-Controlled Subsidiary, Journey Medical Corporation, Receives ...
Fortress Biotech, Inc. (NASDAQ: FBIO) announced through its majority-controlled subsidiary, Journey Medical Corporation, that the U.S. Food and Drug Administration (FDA) has approved Emrosi™ ...
pharmaphorum
10 天
Journey slips on FDA approval of rosacea therapy
Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care ...
10 天
US FDA approves Journey Medical's drug for long-term skin condition
The U.S. Food and Drug Administration has approved Journey Medical's drug for the treatment of a long-term skin condition ...
MedPage Today
11 天
FDA Approves New Option for Rosacea
versus both doxycycline (60-63%) or placebo (46-47%). According to the prescribing information, dyspepsia was the most common ...
fox61
14 天
Heritage, Apotex agree to pay $49.1 million settlement in Connecticut-led drug price fixing ...
This settlement foreshadows the first court trial in this series of anti-trust price fixing investigations into the generic drug industry.
14 天
AG Tong: Drug companies to pay damages for price-fixing in CT-led settlement
People who bought certain generic prescription drugs could be eligible for compensation after an investigation into illegal ...
Federal Register
15 天
Product-Specific Guidances; Revised Draft Guidances for Industry; Availability
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈